BACKGROUND: Almost 400,000 female pelvic reconstructive operations were performed in 2010 for urinary incontinence and pelvic organ prolapse in the United States, and it is likely that this will continue to increase each year. There is a lack of population-based data evaluating the risk of blood transfusion after urogynecologic procedures. OBJECTIVE: We sought to assess the incidence of blood transfusion related to pelvic reconstructive surgery in a large national surgical quality database and to identify transfusion-associated risk factors. STUDY DESIGN: This retrospective cohort study was performed using the National Surgical Quality Improvement Program database from the years 2010 through 2014. All women undergoing surgery for pelvic floor disorders were identified by Current Procedural Terminology code. Demographic and clinical variables were abstracted. The incidence of blood transfusion was determined. A multivariate logistic regression analysis was performed to identify clinical factors independently associated with blood transfusion. RESULTS: A total of 54,387 women underwent pelvic reconstructive surgery from 2010 through 2014 in the National Surgical Quality Improvement Program database. Of these subjects, 686 (1.26%) received a blood transfusion. The median age was 57 (range 28-89) years. Of the population, 0.81% was underweight (body mass index <18.5), 27.0% was normal weight (body mass index 18.5-24.9), 35.6% was overweight (body mass index 25-29.9), and 36.7% was obese (body mass index 30). The majority of subjects in the study cohort were Caucasian (91.4%) followed by African Americans (4.6%); the remainder included Asian, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander. Hispanic ethnicity was reported in 9.3% of the population. American Society of Anesthesiologists class 1 and 2 represented a majority of the sample (76.5%). Concomitant hysterectomy was performed in 20,735 (38.1%) of the population. In the multivariate analysis, preoperative hematocrit <30% (odds ratio, 13.68; 95% confidence interval, 10.65e17.59), history of coagulopathy (odds ratio, 3.74; 95% confidence interval, 2.50e5.60), and concomitant hysterectomy (odds ratio, 1.77; 95% confidence interval, 1.49e2.12) were factors independently associated with receiving blood transfusion (all P < .05). When compared to American Society of Anesthesiologists class 1, patients who were class 3 (odds ratio, 2.82, P < .01; 95% confidence interval, 2.02e3.93) or class 4 (odds ratio, 6.56, P < .01; 95% confidence interval, 3.65e11.78) were more likely to require a transfusion. When compared to Caucasians, African Americans (odds ratio, 1.73, P < .01; 95% confidence interval, 1.27e2.36) and Hispanics (odds ratio, 1.92, P < .01; 95% confidence interval, 1.54e2.40) were more likely to require a transfusion. In this cohort, overweight (odds ratio, 0.75; 95% confidence interval, 0.62e0.93) and obese (odds ratio, 0.61; 95% confidence interval, 0.49e0.75) subjects were less likely to receive a transfusion. When compared to a vaginal approach, patients who had a minimally invasive approach (odds ratio, 0.63; 95% confidence interval, 0.49e0.83) were less likely to receive a transfusion, while those with an open approach were more likely to receive a transfusion (odds ratio, 5.43; 95% confidence interval, 4.49e6.56). Age was not a risk factor for transfusion. CONCLUSION: Transfusion after pelvic reconstructive surgery is uncommon. The variables associated with transfusion are preoperative hematocrit <30%, American Society of Anesthesiologists class, bleeding disorders, nonwhite race, Hispanic ethnicity, and concomitant hysterectomy. Recognition of these factors can help guide preoperative counseling regarding transfusion risk after pelvic reconstructive surgery and individualize preoperative preparation.
Introduction
In 2010, almost 400,000 female pelvic reconstructive operations were performed in the United States for urinary incontinence and pelvic organ prolapse ranging from minor outpatient procedures to treat stress urinary incontinence to major pelvic reconstructive procedures. It is likely that this number will continue to increase annually. 1 While the procedure types are diverse, the majority are considered low risk. Population-based data demonstrated a relatively low incidence of major complications including venous thromboembolism, stroke, and death following pelvic reconstructive procedures. [2] [3] [4] While anecdotally the incidence of blood transfusion related to these procedures is low, there is a dearth of population-based data regarding that complication.
Surgical blood loss is one of the most common reasons for blood transfusion, accounting for approximately 20% of all blood transfusions in the United States. 5 General surgical, cardiac, and orthopedic operations have a particularly high risk of transfusion with reported rates as high as 40% depending on the procedure. 6 The incidence of transfusion after gynecologic surgery appears to be significantly lower. Using National Surgical Quality Improvement Program (NSQIP) data from 2008 through 2009, Richards and colleagues 7 found that the transfusion rate was 3.3% in patients undergoing myomectomy or hysterectomy by any route. The rate of transfusion after minimally invasive hysterectomy appears to be slightly lower with a reported range of 0.8-1.9%. [8] [9] [10] While there are published transfusion rates for specific urogynecologic procedures, 
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there is a lack of population-based data in this area. [11] [12] [13] We hypothesize that the incidence of blood transfusion after urogynecologic procedures is lower than what has been reported in the benign gynecology literature.
Proper preoperative counseling of patients should include a comprehensive discussion of surgical complications including the possibility of blood transfusion and its associated sequelae. A better understanding of the factors that lead to an increased incidence of blood transfusion in the urogynecologic population would facilitate a more informed discussion of the risk with our patients. Understanding what demographic and clinical factors are associated with the need for blood transfusion in female pelvic reconstructive surgery will enhance surgeons' ability to provide more individualized counseling.
The primary aim of this study was to use population-based data to estimate the incidence of transfusion among patients undergoing urogynecologic procedures. We further sought to identify what factors are associated with perioperative transfusion in this population.
Materials and Methods
We conducted a retrospective cohort study using 2010 through 2014 data from the NSQIP. NSQIP is a large national database that collects deidentified data on >240 variables, including preoperative risk factors, intraoperative variables, and postoperative outcomes for patients undergoing surgical procedures in both the inpatient and outpatient setting. Each subject in the database has a unique case identification number and data are audited annually thus avoiding duplications if >1 procedure was performed at the same time.
14 This study was deemed to be exempt by the Ohio State University Institutional Review Board.
Patients age 18 years were included in the study cohort if they had undergone any female pelvic medicine and reconstructive surgery (FPMRS) procedure based on Current Procedural Terminology codes. These codes (Supplemental Table 1 ) included procedures for urinary incontinence, apical prolapse, prolapse of the anterior wall, prolapse of the posterior wall, prolapse graft/mesh augmentation, procedures on the urinary system, relevant procedures on the genital system, and relevant procedures involving the anorectal system. Procedures were further categorized as incontinence, prolapse, combined, or other. Women were excluded if they had a malignancy or underwent a procedure outside the scope of practice of a FPMRS surgeon. Demographic data and clinical variables including transfusion status were collected for the included subjects.
Data were examined for missing and extreme values. We used c 2 tests to examine differences in the distributions of variables. Multivariable logistic regression was used to estimate the odds of blood transfusion for various factors while controlling for other covariates. Factors examined included concomitant hysterectomy, body mass index (BMI), age, American Society of Anesthesiologists (ASA) class, preoperative hematocrit <30%, surgical approach, history of coagulopathy, and race/ethnicity. A sensitivity analysis was performed to assess the impact of limiting the sample to patients who underwent the 15 most frequent procedures in the database (Supplemental Table 2 ). Data on BMI were further analyzed to identify any trends associated with that variable. Variables were selected based on a review of the literature.
15-17 Data were analyzed using software (Stata 13.1; StataCorp, College Station, TX).
Results
From 2010 through 2014, there were 54,387 women in the NSQIP database who underwent pelvic reconstructive surgery. The median age of patients was 57 (range 28-89) years. The majority of patients were overweight or obese: 35.6% (BMI 25-29.9) and 36.7% (BMI 30), respectively. Most patients were Caucasian (91.4%), with 4.6% being African American, and the remainder being Asian, American Indian/Alaska Native, or Native Hawaiian/Pacific Islander. Hispanic ethnicity was reported by 9.3% of patients. ASA class 1 and 2 represented a majority of the sample (76.5%). Concomitant hysterectomy was performed in 38.1% of the population. The incidence of vaginal approach was 75.8%, while the incidence of minimally invasive and vaginal approach was 18.1% and 6.1%, respectively. The distribution of surgical route was similar among the 4 BMI categories with the exception that the underweight category had more open procedures (9.2%) when compared to healthy weight (6.3%), overweight (5.9%), and obese (6.0%) categories.
The overall incidence of blood transfusion in this population was 1.26%. When the analysis was limited to the 15 most frequently performed procedures, the transfusion rate was similar at 1.18%. These procedures comprised 76.9% of the original sample. Incidence varied by surgical approach with vaginal and minimally invasive procedures having the lowest incidence (0.9%) and open procedures having the highest (6.9%). The incidence of transfusion was similar among the types of procedures performed. Incontinence procedures had a transfusion rate of 0.99% compared to the rates of prolapse and combined procedures at 1.05% and 1.21%, respectively. Other major drivers of transfusion in this population were hematocrit <30% with a transfusion rate of 20.4%, and history of a bleeding disorder with a transfusion rate of 7.4%. Selected characteristics of patients by transfusion status are shown in Table 1 .
In the adjusted analysis, preoperative hematocrit <30% (odds ratio [OR], 13.68), history of coagulopathy (OR, 3.74), and concomitant hysterectomy (OR, 1.77) were significantly associated (P < .05) with the odds of perioperative blood transfusion. When compared to ASA class 1, patients who were class 2 (OR, 1.24), class 3 (OR, 2.82), or class 4 (OR, 6.565) had a significantly increased odds of blood transfusion (all P < .05). When compared to Caucasians, African Americans (OR, 1.73) and Hispanics (OR, 1.92) had a significantly increased odds of postoperative blood transfusion (all P < .05). In this cohort, overweight (OR, 0.75; P < .05) and obese (OR, 0.61; ajog.org P <.05) subjects had a decreased odds of transfusion (Table 2) .
Comment
Knowledge and understanding of potential surgical risks is critical when counseling patients about management options for pelvic floor disorders. There are effective nonsurgical treatments for many pelvic floor disorders, and surgical management is often considered elective. There is limited information on the incidence of transfusion following gynecologic surgery and specifically pelvic reconstructive surgery. We studied a large nationally representative sample of women who underwent pelvic reconstructive surgery in the United States. The overall incidence of transfusion following these procedures is very low at 1.26%.
Our findings are similar to published transfusion rates for specific urogynecologic procedures. The transfusion rate after abdominal sacrocolpopexy has been reported as 2.1% and from 0.5-0.8% after minimally invasive sacrocolpopexy. 12, 18, 19 A multicenter randomized control trial reported rates of transfusion of 3.7% and 2.2% for uterosacral ligament suspension and sacrospinous ligament fixation, respectively. 13 We found the transfusion rate to be 1.05% for procedures done for prolapse only, reflecting a combination of open, vaginal, and minimally invasive approaches. The rate of transfusion after placement of a synthetic midurethral sling is reported as 0.3%. 20 We found the transfusion rate to be 0.99% for procedures done for incontinence only. The difference is likely secondary to inclusion of various surgical approaches. The rate of transfusion reported in the Colpopexy and Urinary Reduction Efforts trial was 5.5%. 11 This is comparable to 6.9% incidence of transfusion for open abdominal cases from our findings.
We identified several factors associated with perioperative blood transfusion in this population: being African American or Hispanic, preoperative hematocrit <30%, history of a bleeding disorder, ASA class 2, concomitant hysterectomy, and open surgical approach. Overweight or obese status was associated with decreased odds of transfusion. These findings are similar to previously published data. Preoperative anemia increases the risk of transfusion in patients undergoing myomectomy or hysterectomy.
7 ASA class and preoperative hemoglobin have been shown to impact the transfusion rate after orthopedic procedures.
15, 16 Previous studies in the field of colorectal surgery have identified preoperative hemoglobin, medical comorbidities, and malignancy as significant factors associated with transfusion. 17 Abdominal surgical approach is associated with an increased risk of transfusion in comparison to 
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vaginal approach when performing hysterectomy for benign indications. 21 We are not able to determine whether open abdominal procedures were planned or converted from minimally invasive approaches in the NSQIP database. However, it is unlikely that this represents a large percentage of open cases given the available data suggesting very low rates of conversion in urogynecologic procedures. The vascular injury rate is low (0.7%) in minimally invasive sacrocolpopexy and a conversion rate of 1.9% for all causes has been reported. 12 As expected, a history of a bleeding disorder was independently associated with perioperative blood transfusion as well. Our finding that the incidence of transfusion is higher in African American subjects is similar to rates found in a previous study of cardiac and orthopedic procedures. 22 Age was not found to be an independent factor associated with transfusion in our study. Sung and colleagues 23 demonstrated that women age >80 years may experience perioperative mortality rates up to 13.6-fold higher, and morbidity rates up to 1.3-fold higher than younger patients with or without underlying comorbidities. However, the specific relationship between blood transfusion and age was not consistent in that study and does not appear to be linked in this data set. Notably, the only age group associated with an increased risk of transfusion was women <30 years old, which may reflect a population undergoing more complex reconstructive procedures related to congenital disorders.
Interestingly, obesity was not associated with increased odds of transfusion in our study. We found being overweight or obese to be associated with a decreased odds of perioperative transfusion. There are contrasting reports identifying obesity as a risk factor for transfusion. [16] [17] [18] The lack of association in our study may be related to differing surgical approaches based on BMI. While we were able to control for route of surgery, we did not control for the specific types of procedures. Nam and colleagues 24 found that obesity was protective for transfusion in patients who had a vaginal approach. They theorized that since total blood volume increases with increased body weight, the same blood loss for normal or underweight patients may have an increased impact on postoperative hemoglobin. 24 An analysis of data from the Colpopexy and Urinary Reduction Efforts trial also found no difference in transfusion rate between obese and healthy weight patients.
11
There are several strengths of this study. The NSQIP database offers a large population-based sample and standardized, audited data thereby increasing both internal and external validity. The database also specifically tracks postoperative complications up to 30 days following surgery not only during inpatient hospitalization. In addition to the population-based nature of the database used, the inclusion of all procedures within the scope of the typical FPMRS surgeon increases the generalizability of our findings. To further focus our findings on the most pertinent FPMRS procedures, we also performed a sensitivity analysis to look at the transfusion rate in the 15 most common FPMRS procedures from the database and the rate did not change meaningfully. This analysis represented a majority of included cases.
One limitation of this study is the lack of information regarding the timing of Future work in this area should focus on the utility and cost-effectiveness of routine preoperative laboratory testing for patients undergoing pelvic reconstructive surgery. Considering the overall low risk of transfusion, it is unlikely that routine hematologic testing and preparation for blood products will be high-yield. Using the identified risk factors from this study may allow for more judicious use of preoperative testing resources.
Neither the American Urogynecologic Society nor the American Congress of Obstetricians and Gynecologists provide guidelines for preoperative laboratory analysis. Often this testing is dictated by institutional or individual practice patterns. Ransom and colleagues 25 retrospectively reviewed vaginal hysterectomies at 1 institution and concluded that routine preoperative type-and-screen testing before vaginal hysterectomy does not improve patient care and is not cost-effective. The same group reported on data from 2 institutions and found that routine preoperative type-and-screen testing for elective laparoscopic procedures does not enhance patient care. 26 No such data exist on procedures done to correct pelvic floor defects.
In an era where quality of medical care is increasingly being linked to cost, it is important to identify cost-saving measures that will not negatively impact our patients' clinical outcomes. Avoidance of preoperative laboratory tests such as type and screen is a potential cost-saving measure and warrants purposeful study. Recognition of the above factors can help guide preoperative counseling regarding transfusion risk after pelvic reconstructive surgery and individualize preoperative workup without compromising patient care.
Conclusion
In the NSQIP database from 2010 through 2014, the overall incidence of blood transfusion after female pelvic reconstructive surgery was low at 1.26%. Factors associated with an increased odds of perioperative transfusion included preoperative hematocrit <30%, increasing ASA class, nonwhite race, Hispanic ethnicity, concomitant hysterectomy, and an open surgical approach. These findings can be used to improve patient counseling regarding surgical options for the management of pelvic floor disorders. n SUPPLEMENTAL ajog.org
